{"id":15523,"date":"2013-12-09T13:48:00","date_gmt":"2013-12-09T12:48:00","guid":{"rendered":"http:\/\/theark.ch\/nano2life-627\/"},"modified":"2013-12-09T13:48:00","modified_gmt":"2013-12-09T11:48:00","slug":"nano2life-627","status":"publish","type":"post","link":"https:\/\/theark.ch\/fr\/news\/nano2life-627\/","title":{"rendered":"Nano2Life"},"content":{"rendered":"<p>Nano2Life, le premier r\u00e9seau d&#39;excellence dans les Nanotechnologies tiendra ses assises annuelles \u00e0 Champ\u00e9ry en janvier prochain (<a href=\"http:\/\/www.nano2life.de\/\" target=\"_blank\" rel=\"noopener\">www.nano2life.de<\/a>).<\/p>\n<p>Les start-ups int\u00e9grant les nanotechnologies pour des applications en sciences de la vie (microfluidique \u00e0 des fins de diagnostics, etc.) ont la possibilit\u00e9 de tenir un \u00ab\u00a0pitch\u00a0\u00bb et de pr\u00e9senter un poster le vendredi 11 janvier 2008.<\/p>\n<p>Inscription au plus vite aupr\u00e8s de info@bioark.ch<\/a>.<\/p>\n<p>Pour plus d&#39;informations: <a class=\"darkblue\" href=\"http:\/\/theark.ch\/pages\/OpenOtherSite.cfm?TheUrl=http%3A%2F%2Fwww%2Enano2life%2Ede\" target=\"_blank\" rel=\"noopener\"><font color=\"#84609e\"><u> Liens<\/u><\/font><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Nano2Life, le premier r\u00e9seau d&#39;excellence dans les Nanotechnologies tiendra ses assises annuelles \u00e0 Champ\u00e9ry en janvier prochain (www.nano2life.de). Les start-ups int\u00e9grant les nanotechnologies pour des applications en sciences de la vie (microfluidique \u00e0 des fins de diagnostics, etc.) ont la possibilit\u00e9 de tenir un \u00ab\u00a0pitch\u00a0\u00bb et de pr\u00e9senter un poster le vendredi 11 janvier 2008. [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[190],"tags":[],"class_list":["post-15523","post","type-post","status-publish","format-standard","hentry","category-biotechnologies"],"acf":[],"_links":{"self":[{"href":"https:\/\/theark.ch\/fr\/wp-json\/wp\/v2\/posts\/15523","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/theark.ch\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/theark.ch\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/theark.ch\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/theark.ch\/fr\/wp-json\/wp\/v2\/comments?post=15523"}],"version-history":[{"count":0,"href":"https:\/\/theark.ch\/fr\/wp-json\/wp\/v2\/posts\/15523\/revisions"}],"wp:attachment":[{"href":"https:\/\/theark.ch\/fr\/wp-json\/wp\/v2\/media?parent=15523"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/theark.ch\/fr\/wp-json\/wp\/v2\/categories?post=15523"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/theark.ch\/fr\/wp-json\/wp\/v2\/tags?post=15523"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}